2022
Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease
Binyamin G, Gaston S, Konstantino E, Konstantino M, Lansky A. Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease. 2022, 673-688. DOI: 10.1016/b978-0-12-821451-0.00006-9.Peer-Reviewed Original ResearchPeripheral arterial diseaseAtherosclerotic peripheral arterial diseaseArterial diseaseBalloon angioplastyRevascularization strategyImpaired perfusionClinical syndromeBalloon catheterInvasive treatmentAngioplastyAngioplasty devicesDiseaseClinical applicationStentingPatientsCatheterSyndromePerfusionMainstay
2011
IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL
Kovacic J, Mehran R, Dangas G, Claessen B, Parise H, Fahy M, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Stone G. IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1633. DOI: 10.1016/s0735-1097(11)61633-1.Peer-Reviewed Original Research
2010
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial.
Applegate RJ, Hermiller JJ, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky AJ, Sudhir K, Stone GW. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention 2010, 6: 437-46. PMID: 20884430, DOI: 10.4244/eij30v6i4a75.Peer-Reviewed Original ResearchConceptsPaclitaxel-eluting stentsClinical outcomesStent typeMajor adverse cardiac eventsTwo-year event ratesSPIRIT IIIPaclitaxel-eluting coronary stentsSPIRIT III trialYear clinical outcomesAdverse cardiac eventsCardiac eventsIII trialsPE groupTwo-vesselPatientsEvent ratesCoronary stentsTrialsVessel treatmentStentsOutcomesVesselsSignificant interactionStentingLesions
2009
Impact of Thienopyridine Administration Prior to Primary Stenting in Acute Myocardial Infarction
RABBANI LE, IYENGAR S, DANGAS GD, GRINES CL, COX DA, GARCIA E, TCHENG JE, GRIFFIN JJ, GUAGLIUMI G, STUCKEY T, TURCO M, STANT J, FAHY M, LANSKY AJ, MEHRAN R, STONE GW. Impact of Thienopyridine Administration Prior to Primary Stenting in Acute Myocardial Infarction. Journal Of Interventional Cardiology 2009, 22: 378-384. PMID: 19496901, DOI: 10.1111/j.1540-8183.2009.00474.x.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplasty, Balloon, CoronaryAntibodies, MonoclonalAspirinConfidence IntervalsDrug Therapy, CombinationDrug-Eluting StentsFemaleHumansImmunoglobulin Fab FragmentsKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionMyocardial RevascularizationOdds RatioPlatelet Aggregation InhibitorsPreoperative CarePyridinesTime FactorsConceptsMajor adverse cardiovascular eventsAcute myocardial infarctionTarget vessel revascularizationIschemic target vessel revascularizationPrimary stentingThienopyridine administrationLoading doseTH patientsStent implantationMyocardial infarctionClopidogrel loading doseAdverse cardiovascular eventsSuperior clinical outcomesBare-metal stentingAbciximab useCADILLAC trialCardiovascular eventsVessel revascularizationClinical outcomesMetal stentingProcedural characteristicsOperator's discretionPatientsStentingCore lab
2008
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: Results from the CADILLAC trial
Lansky AJ, Tsuchiya Y, Brener M, Mehran R, Cristea E, Pietras C, Grines CL, Cox DA, Garcia E, Tcheng JE, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Leon MB, Moses J, Stone GW. Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: Results from the CADILLAC trial. Catheterization And Cardiovascular Interventions 2008, 72: 917-924. PMID: 19016469, DOI: 10.1002/ccd.21714.Peer-Reviewed Original ResearchMeSH KeywordsAbciximabAgedAngioplasty, Balloon, CoronaryAntibodies, MonoclonalAspirinClopidogrelCoronary AngiographyDrug Therapy, CombinationEuropeFemaleHemorrhageHumansImmunoglobulin Fab FragmentsMaleMiddle AgedMulticenter Studies as TopicMyocardial InfarctionMyocardial IschemiaPlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicRetrospective StudiesRisk AssessmentStentsThrombosisTiclopidineTime FactorsTreatment OutcomeUnited StatesConceptsAcute myocardial infarctionPrimary stentingCADILLAC trialRecurrent ischemiaSevere bleedingMyocardial infarctionEfficacy of clopidogrelMore recurrent ischemiaTIMI 0/1 flowSimilar clinical outcomesTiclopidine treatmentAngiographic characteristicsClopidogrel useIndependent predictorsClinical outcomesMultivariable analysisRandomized trialsStent thrombosisStent implantationOperator's discretionClopidogrelStentingPatientsTiclopidineRelative safety
2005
Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
Lansky A, Piedras C, Costa R. Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. ACC Current Journal Review 2005, 14: 44-45. DOI: 10.1016/j.accreview.2005.08.053.Peer-Reviewed Original Research
2003
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)
Ashby DT, Aymong EA, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Carroll JD, Turco M, Lansky AJ, Stone GW. Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). The American Journal Of Cardiology 2003, 92: 1095-1098. PMID: 14583363, DOI: 10.1016/j.amjcard.2003.06.006.Peer-Reviewed Original ResearchConceptsSuccessful balloon angioplastyAcute myocardial infarctionBalloon angioplastyRoutine stentingMyocardial infarctionEvent-free survivalPrimary balloon angioplastySuboptimal balloon angioplastyCADILLAC trialUnsuccessful dilatationPrimary interventionAngioplastyStentingInfarctionPatientsDilatationTrialsComparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients ≥80 years old versus those <80 years old
Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Lansky AJ, Stone GW, Moses JW, Leon MB. Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients ≥80 years old versus those <80 years old. The American Journal Of Cardiology 2003, 92: 443-446. PMID: 12914876, DOI: 10.1016/s0002-9149(03)00663-5.Peer-Reviewed Original ResearchConceptsHigh technical success rateCoronary arterial stentingOne-year outcomesTechnical success rateHigh mortality rateComplication rateMultivessel stentingArterial stentingHospital cardiacMortality rateYounger counterpartsSuccess rateStentingPatientsHospitalPresent studyOutcomesYearsMultivesselOctogenariansCardiac
2002
Late Vascular Response to Repeat Stenting for In-Stent Restenosis With and Without Radiation
Morino Y, Limpijankit T, Honda Y, Lansky AJ, Waksman R, Bonneau HN, Yock PG, Mintz GS, Fitzgerald PJ. Late Vascular Response to Repeat Stenting for In-Stent Restenosis With and Without Radiation. Circulation 2002, 105: 2465-2468. PMID: 12034650, DOI: 10.1161/01.cir.0000018949.39445.40.Peer-Reviewed Original ResearchMeSH KeywordsBlood Vessel Prosthesis ImplantationBrachytherapyCohort StudiesCoronary RestenosisDisease ProgressionDouble-Blind MethodFollow-Up StudiesGamma RaysHumansIridium RadioisotopesPlatelet Aggregation InhibitorsRandomized Controlled Trials as TopicRecurrenceReoperationStentsTiclopidineTimeTreatment OutcomeUltrasonography, InterventionalVascular PatencyConceptsLumen volume indexISR lesionsPlacebo patientsLate vascular responseAcute angiographic resultsIntravascular ultrasound analysisIn-Stent RestenosisPlacebo groupAngiographic resultsVascular responsesAdditional lumenNeointimal proliferationStent restenosisIrradiated groupPatientsStent overlapLesionsVolume indexUltrasound analysisSafety of radiationLong-term advantagesStent strutsSignificant decreaseStentingRestenosisPrimary stenting optimizes the outcome of women with acute myocardial infarction: results from the CADILLAC trial
Lansky A, Grines C, Desai K, Cristea E, Corral M, Cox D, Gedney S, Griffin J, Stuckey T, Garcia E, Rutherford B, Stone G. Primary stenting optimizes the outcome of women with acute myocardial infarction: results from the CADILLAC trial. Journal Of The American College Of Cardiology 2002, 39: 39. DOI: 10.1016/s0735-1097(02)80165-6.Peer-Reviewed Original ResearchDirect stenting improves target lesion revascularization in saphenous vein graft lesions: an intravascular ultrasound-guided study
Abizaid A, Mehran R, Mintz G, Lansky A, Stone G, Abizaid A, Dangas G, Limpijankit T, Iakovou Y, Moses J, Leon M. Direct stenting improves target lesion revascularization in saphenous vein graft lesions: an intravascular ultrasound-guided study. Journal Of The American College Of Cardiology 2002, 39: 35. DOI: 10.1016/s0735-1097(02)80150-4.Peer-Reviewed Original Research
2001
Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting
Dangas G, Mehran R, Abizaid A, Curry B, Lansky A, Kent K, Pichard A, Satler L, Paliou M, Stone G, Leon M. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. The American Journal Of Cardiology 2001, 87: 470-472. PMID: 11179539, DOI: 10.1016/s0002-9149(00)01408-9.Peer-Reviewed Original Research